UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000022017
Receipt No. R000025290
Official scientific title of the study Effects of High- and Low-velocity Resistance Training on Gait Kinematics and Kinetics in Individuals with Hip Osteoarthritis
Date of disclosure of the study information 2016/04/22
Last modified on 2016/04/21 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effects of High- and Low-velocity Resistance Training on Gait Kinematics and Kinetics in Individuals with Hip Osteoarthritis
Title of the study (Brief title) High- and Low-velocity Resistance Training for Hip Osteoarthritis
Region
Japan

Condition
Condition Hip Osteoarthritis
Classification by specialty
Orthopedics Rehabilitation medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effects of high- and low-velocity resistance training on gait kinematics and kinetics in patients with hip osteoarthritis
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Joint angle, joint moment during gait (Parameters are assessed at baseline and 8 weeks after intervention)
Key secondary outcomes Walking speed, cadence, stride length, muscle strength, muscle power, pain, Harris Hip Score, Timed Up and Go test, 3 minutes walking distance (Parameters are assessed at baseline and 8 weeks after intervention)

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Active
Stratification YES
Dynamic allocation
Institution consideration
Blocking YES
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Eight-week daily home-based resistance training at high-velocity consisting of hip abduction, extension and flexion and knee extension
Interventions/Control_2 Eight-week daily home-based resistance training at low-velocity consisting of hip abduction, extension and flexion and knee extension
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Patients who diagnosed with hip osteoarthritis
Ability to live community and to walk independently
Key exclusion criteria Patients after total hip arthroplasty
Patients with a neurological disorder
Patients with a cardiovascular disease
Patients with knee, ankle, or back symptoms that limited their function
Patients who cannot walk 6m without assistive device
Patients who received prior physical therapy or other physical activity program
Target sample size 64

Research contact person
Name of lead principal investigator Noriaki Ichihashi
Organization Kyoto University
Division name Human Health Sciences, Graduate School of Medicine
Address 53,Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507 Japan
TEL 075-751-3935
Email ichihashi.noriaki.5z@kyoto-u.ac.jp

Public contact
Name of contact person Yoshirhiro Fukumoto
Organization Kobe Gakuin University
Division name Faculty of Rehabilitation
Address 518, Arise, Ikawadani-cho, Nishi-ku, Kobe, Hyogo 651-2180 Japan
TEL 078-974-2461
Homepage URL
Email fukumoto@reha.kobegakuin.ac.jp

Sponsor
Institute Kyoto University
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization MEXT(Japan)
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 04 Month 22 Day

Progress
Recruitment status Completed
Date of protocol fixation
2010 Year 03 Month 30 Day
Anticipated trial start date
2010 Year 06 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 04 Month 21 Day
Last modified on
2016 Year 04 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025290